Celldex Therapeutics (CLDX) PT Raised to $72 at Wells Fargo
Tweet
Share
E-mailGet Alerts CLDX Hot Sheet
Price: $39.24 --0%
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Join SI Premium – FREE
Wells Fargo analyst Derek Archila raised the price target on Celldex Therapeutics (NASDAQ: CLDX) to $72.00 (from $48.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Macquarie Starts Parkway Life REIT (PREIT:SP) (PRKWF) at Outperform
- Hamamatsu Photonics KK (6965:JP) PT Raised to JPY2,100 at Nomura/Instinet
- JPMorgan Downgrades Zhongsheng Group Holdings (881:HK) (ZSHGY) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
